Objective: Current treatments have only a modest effect on impairment in Alzheimer's
Dementia (AD) and there is no treatment currently licensed for Mild Cognitive Impairment …

In 1997, a double-blind, placebo-controlled, randomized, multicenter, 2-year study
conducted by the Alzheimer's Disease Cooperative Study showed that treatment with the …

Many studies have been published so far showing the significant role of oxidative stress in
the pathogenesis of Alzheimer's disease (AD), and the role of antioxidants as protective …

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder representing the
most common form of dementia and the most feared highly disabling age-related condition …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with
cognitive decline and characterized by amyloid-β plaques and neurofibrillary tau tangles …

Background: Alzheimer's disease (AD) is a neurological disease that is characterized by
cognitive deficits and intellectual loss (Oberg & Mischley, 2008). With Alzheimer's so …

In 1997, a double-blind, placebo-controlled, randomized, multicenter, 2-year study
conducted by the Alzheimer's Disease Cooperative Study showed that treatment with the …

There is compelling evidence that oxidative stress is involved in Alzheimer's disease
pathogenesis, and several lines of evidence indicate that administration of antioxidants may …

Therapeutic interventions for the prodromal stages of dementia are currently being sought
with a view to delaying if not preventing disease onset. Uncertainty as to whether cognitive …

Background Previous studies have suggested that increased antioxidant intakes might
reduce risk of cognitive disorders including Alzheimer's disease (AD). Which avenue of …